Denali Therapeutics Inc.
ENGINEERED BISPECIFIC PROTEINS

Abstract:

In one aspect, bispecific proteins having the ability to specifically bind to two antigens, and having an Fc polypeptide that comprises a modified CH3 domain and specifically binds to a transferrin receptor, are provided.